Multiplex bacterial PCR for antibiotic stewardship in pneumonia - Author's reply
- PMID: 35926546
- DOI: 10.1016/S2213-2600(22)00269-7
Multiplex bacterial PCR for antibiotic stewardship in pneumonia - Author's reply
Conflict of interest statement
DS reports an unrestricted grant from Curetis; grants from AstraZeneca, Weinmann, ResMed, and Boston Scientifics; and honoraria from and participation on data safety monitoring or advisory boards for CSL Behring, Berlin-Chemie Menarini, Novartis, GlaxoSmithKline, AstraZeneca, Vifor, Merck, Chiesi, and Sanofi. AMD declares no competing interests.
Comment on
-
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial.Lancet Respir Med. 2022 Sep;10(9):877-887. doi: 10.1016/S2213-2600(22)00086-8. Epub 2022 May 23. Lancet Respir Med. 2022. PMID: 35617987 Clinical Trial.
-
Multiplex bacterial PCR for antibiotic stewardship in pneumonia.Lancet Respir Med. 2022 Sep;10(9):e78. doi: 10.1016/S2213-2600(22)00264-8. Epub 2022 Aug 1. Lancet Respir Med. 2022. PMID: 35926543 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical